ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

RLAY Relay Therapeutics Inc

7,2499
0,5899 (8,86%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Relay Therapeutics Inc RLAY NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,5899 8,86% 7,2499 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,78 6,62 7,16 7,08 6,66
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:05GLOBERelay Therapeutics Reports First Quarter 2024 Financial..
25.4.202422:05GLOBERelay Therapeutics to Announce First Quarter 2024 Financial..
11.4.202422:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
26.2.202422:05GLOBERelay Therapeutics to Participate in Three Upcoming Investor..
22.2.202422:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
22.2.202422:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202422:10EDGAR2Form 8-K - Current report
22.2.202422:05GLOBERelay Therapeutics Reports Fourth Quarter and Full Year 2023..
15.2.202422:05GLOBERelay Therapeutics to Announce Fourth Quarter and Full Year..
01.2.202422:05GLOBERelay Therapeutics to Participate in the Guggenheim..
31.1.202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202415:22EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
10.1.202415:14EDGAR2Form D - Notice of Exempt Offering of Securities
08.1.202413:05EDGAR2Form 8-K - Current report
08.1.202413:00GLOBERelay Therapeutics Announces $30 Million Private Placement..
02.1.202422:05GLOBERelay Therapeutics to Present at 42nd Annual J.P. Morgan..
29.12.202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.12.202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.11.202322:16EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
07.11.202322:05GLOBERelay Therapeutics to Participate in Stifel 2023 Healthcare..
02.11.202321:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:10EDGAR2Form 8-K - Current report
02.11.202321:05GLOBERelay Therapeutics Reports Third Quarter 2023 Financial..
01.11.202321:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.11.202321:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.10.202322:05GLOBERelay Therapeutics to Announce Third Quarter 2023 Financial..
12.10.202322:13EDGAR2Form 8-K - Current report
12.10.202322:05GLOBERelay Therapeutics Announces Initial RLY-4008..
29.9.202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.9.202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.9.202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.9.202322:05GLOBERelay Therapeutics to Present Clinical Data on RLY-4008 in..
08.8.202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202322:14EDGAR2Form 8-K - Current report
08.8.202322:02GLOBERelay Therapeutics Reports Second Quarter 2023 Financial..
01.8.202322:05GLOBERelay Therapeutics to Announce Second Quarter 2023 Financial..
31.7.202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.7.202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.6.202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.6.202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.5.202323:01GLOBERelay Therapeutics Announces Full Dose Escalation Data for..
24.5.202322:05GLOBERelay Therapeutics to Participate in Two Upcoming Investor..
04.5.202322:05GLOBERelay Therapeutics Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock